Compare Flux Power Holdings Inc (FLUX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Flux Power Holdings Inc trades at $0.69 (market cap $15.37M), while State Street SPDR S&P Biotech ETF trades at $152.02. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals.
| FLUX | XBI | |
|---|---|---|
Market Cap | $15.37M | — |
Sector | Utilities | Broad Market / Factor |
52-Week High | $6.66 | $164.28 |
52-Week Low | $0.71 | $85.16 |
Enterprise Value | $21.53M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.701, down 2.18% today, with a bearish technical signal from moving averages. The company reported a net loss of $6.67M in 2025 with revenue of $66.43M, though the price-to-sales ratio remains low at 0.27. Recent news highlights the launch of SkyEMS 3.0 AI software and new executive hires aimed at growth. Analysts are unanimously bullish with 6 buy ratings, contrasting with negative profitability metrics like a -52.27% ROE.
The outlook hinges on execution of growth initiatives amid persistent losses. Opportunities include market expansion in clean energy and software, while risks involve cash flow volatility and competitive pressures. Investors should weigh analyst optimism against fundamental challenges in the evolving energy storage sector.
XBI trades at $155.19, down 0.23% on the day, with a bullish technical signal from moving averages. Recent news highlights strong biotech sector momentum, with the ETF gaining nearly 17% in a month (24/7 Wall Street, 2026-07-06). Analyst consensus is neutral with a single hold rating, while technical indicators show a neutral RSI and mixed ADX signals. Support is seen near $153, with resistance at $157.
The outlook for XBI is supported by sector strength and M&A activity, but high volatility and a neutral analyst stance suggest cautious optimism. Key risks include regulatory uncertainty and macroeconomic pressures, requiring careful risk management for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
